Sichuan Goldstone Asia Pharmaceutical Inc Sustainability Reports
The company operates a dual-core business framework focused on the research, development, manufacturing, and sale of human pharmaceuticals and health foods, alongside the development of proprietary steel-reinforced plastic composite pipe technologies and mechanical processing equipment. Its primary pharmaceutical portfolio emphasizes anti-cold, antiviral, and respiratory therapies, alongside chemical synthesis raw materials.
Sector: Manufacturing
Country: China
Exchange: Shenzhen Stock Exchange
FIGI: BBG006Q1L2F1
1 reports from 2024 to 2024